Literature DB >> 22318360

[The effects of hormone replacement therapy on mind and brain].

P Baldinger1, G Kranz, A Höflich, M Savli, P Stein, R Lanzenberger, S Kasper.   

Abstract

Hormonal fluctuations during the perimenopausal transition lead to physical discomfort but are also frequently accompanied by mood swings, depressive symptoms, anxiety and sleeping disorders. The important role of the neurotransmitter serotonin in the pathogenesis of anxiety disorders and major depression is unquestioned, but only little is known about the influence of sex hormones on the serotonergic system. This review provides an overview of potential risk factors for the occurrence of affective disorders in the menopausal transition and discusses possible therapeutic options. Current research findings from longitudinal studies testing the efficacy of hormone replacement therapy and antidepressants with effects on the serotonergic neurotransmission on physical and mental discomforts during menopause are presented. Furthermore, studies using positron emission tomography and genetic methods that explore the effects of sex steroids on different components of the serotonergic system are shown. The interactions between estrogen, progesterone and the serotonergic system are described, and possible neurobiological and endocrinological mechanisms underlying depressive symptoms in the perimenopause are elucidated.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22318360     DOI: 10.1007/s00115-011-3456-7

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  32 in total

Review 1.  Consensus paper of the WFSBP Task Force on Biological Markers: biological markers in depression.

Authors:  Rainald Mössner; Olya Mikova; Eleni Koutsilieri; Mohamed Saoud; Ann-Christince Ehlis; Norbert Müller; Andreas J Fallgatter; Peter Riederer
Journal:  World J Biol Psychiatry       Date:  2007       Impact factor: 4.132

2.  Neuropsychiatric function and dehydroepiandrosterone sulfate in elderly women: a prospective study.

Authors:  K Yaffe; B Ettinger; A Pressman; D Seeley; M Whooley; C Schaefer; S Cummings
Journal:  Biol Psychiatry       Date:  1998-05-01       Impact factor: 13.382

3.  Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society.

Authors:  Wulf H Utian; David F Archer; Gloria A Bachmann; Christopher Gallagher; Francine n Grodstein; Julia R Heiman; Victor W Henderson; Howard N Hodis; Richard H Karas; Rogerio A Lobo; JoAnn E Manson; Robert L Reid; Peter J Schmidt; Cynthia A Stuenkel
Journal:  Menopause       Date:  2008 Jul-Aug       Impact factor: 2.953

4.  Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial.

Authors:  C N Soares; O P Almeida; H Joffe; L S Cohen
Journal:  Arch Gen Psychiatry       Date:  2001-06

5.  The Relationship Between Tamoxifen, Estrogen, and Depressive Symptoms.

Authors:  Diane S. Thompson; Cynthia A. Spanier; Victor G. Vogel
Journal:  Breast J       Date:  1999-11       Impact factor: 2.431

6.  Mood effect of raloxifene in postmenopausal women.

Authors:  Natalia B Jarkova; Ferenc Martenyi; Daiva Masanauskaite; Erin L Walls; Vera P Smetnik; Imre Pavo
Journal:  Maturitas       Date:  2002-05-20       Impact factor: 4.342

Review 7.  Effect of reproductive hormones and selective estrogen receptor modulators on mood during menopause.

Authors:  Claudio N Soares; Jennifer R Poitras; Jennifer Prouty
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 8.  Tailoring treatment of depression for women across the reproductive lifecycle: the importance of pregnancy, vasomotor symptoms, and other estrogen-related events in psychopharmacology.

Authors:  Dana D Wise; Angela Felker; Stephen M Stahl
Journal:  CNS Spectr       Date:  2008-08       Impact factor: 3.790

9.  Lack of efficacy of estradiol for depression in postmenopausal women: a randomized, controlled trial.

Authors:  Mary F Morrison; Michael J Kallan; Thomas Ten Have; Ira Katz; Kathryn Tweedy; Michelle Battistini
Journal:  Biol Psychiatry       Date:  2004-02-15       Impact factor: 13.382

10.  Serotonin 1A receptor reductions in postpartum depression: a positron emission tomography study.

Authors:  Eydie L Moses-Kolko; Katherine L Wisner; Julie C Price; Sarah L Berga; Wayne C Drevets; Barbara H Hanusa; Tammy L Loucks; Carolyn C Meltzer
Journal:  Fertil Steril       Date:  2007-06-04       Impact factor: 7.329

View more
  1 in total

1.  Role of stem cell growth factor/c-Kit in the pathogenesis of irritable bowel syndrome.

Authors:  Yuna Chai; Yusheng Huang; Hongmei Tang; Xing Tu; Jianbo He; Ting Wang; Qingye Zhang; Fen Xiong; Detang Li; Zhenwen Qiu
Journal:  Exp Ther Med       Date:  2017-02-20       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.